ALGS Stock Analysis: Buy, Sell, or Hold?
ALGS - Aligos Therapeutics, Inc. Common Stock
$5.59
0.14 (2.57%)
▲
5d:
+1.64%
30d:
+6.48%
90d:
-27.78%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When ALGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALGS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ALGS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ALGS is currently trading at $5.59, which is considered slightly high relative to its 30-day fair value range of $5.14 to $5.65.
Technical Outlook: Technically, ALGS is in a strong downtrend. Immediate support is located at $5.16, while resistance sits at $5.94.
Market Sentiment: ALGS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $56.29 (+906.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALGS is in a strong downtrend. Immediate support is located at $5.16, while resistance sits at $5.94.
Market Sentiment: ALGS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $56.29 (+906.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$5.14 -
$5.65
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 906.9% below Wall St target ($56.29)
Trading Range Analysis
30-Day Trading Range
$5.14 -
$5.65
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$5.16
Resistance Level
$5.94
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.40
Wall Street Target
$56.29
(+906.9%)
Revenue Growth (YoY)
810.0%
Share & Embed Analysis
Last updated: July 04, 2026 9:47 AM ET
Data refreshes hourly during market hours. Next update: 10:47 AM
Data refreshes hourly during market hours. Next update: 10:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
